Indogulf Cropsciences Ltd
Incorporated in 1993, Indogulf Cropsciences Limited is engaged in manufacturing crop protection products, plant nutrients, and biologicals in India.[1]
- Market Cap ₹ 348 Cr.
- Current Price ₹ 55.0
- High / Low ₹ 122 / 49.5
- Stock P/E 8.72
- Book Value ₹ 72.6
- Dividend Yield 0.00 %
- ROCE 12.2 %
- ROE 10.9 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.76 times its book value
- Company's working capital requirements have reduced from 86.4 days to 33.7 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 9.73% over past five years.
- Company has a low return on equity of 12.1% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 443 | 486 | 550 | 552 | 590 | 705 | |
| 404 | 442 | 501 | 493 | 526 | 631 | |
| Operating Profit | 39 | 45 | 49 | 59 | 64 | 74 |
| OPM % | 9% | 9% | 9% | 11% | 11% | 10% |
| 2 | 4 | 3 | -0 | 5 | 8 | |
| Interest | 5 | 6 | 12 | 13 | 15 | 17 |
| Depreciation | 6 | 8 | 10 | 10 | 11 | 11 |
| Profit before tax | 30 | 36 | 30 | 36 | 45 | 53 |
| Tax % | 26% | 26% | 26% | 22% | 29% | 25% |
| 22 | 26 | 22 | 28 | 31 | 40 | |
| EPS in Rs | 9.48 | 11.25 | 9.53 | 12.00 | 6.45 | 6.33 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 9% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 21% |
| TTM: | 31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | 12% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 24 | 24 | 49 | 63 |
| Reserves | 130 | 157 | 180 | 208 | 226 | 396 |
| 79 | 102 | 195 | 159 | 227 | 183 | |
| 178 | 139 | 120 | 154 | 188 | 181 | |
| Total Liabilities | 411 | 421 | 519 | 544 | 690 | 823 |
| 51 | 53 | 69 | 48 | 47 | 49 | |
| CWIP | 6 | 9 | 9 | 23 | 58 | 76 |
| Investments | 3 | 0 | 0 | 0 | 0 | 12 |
| 351 | 359 | 440 | 474 | 585 | 687 | |
| Total Assets | 411 | 421 | 519 | 544 | 690 | 823 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 20 | -7 | -57 | 53 | -15 | -41 | |
| -10 | -10 | -19 | -5 | -40 | -37 | |
| -9 | 16 | 75 | -49 | 61 | 80 | |
| Net Cash Flow | 1 | -1 | -1 | -1 | 7 | 3 |
| Free Cash Flow | 10 | -19 | -77 | 47 | -55 | -69 |
| CFO/OP | 72% | 6% | -95% | 100% | -5% | -36% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 97 | 115 | 117 | 146 | 138 | 0 |
| Inventory Days | 205 | 167 | 201 | 195 | 260 | 258 |
| Days Payable | 138 | 111 | 79 | 109 | 129 | 96 |
| Cash Conversion Cycle | 164 | 171 | 239 | 232 | 268 | 162 |
| Working Capital Days | 62 | 86 | 91 | 111 | 114 | 34 |
| ROCE % | 16% | 12% | 13% | 13% | 12% |
Insights
In beta| Apr 2019 | Feb 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Formulation Capacity (Solid/Powder/Granules) MTPA |
|
|||||
| Technical Grade Capacity TPA / MTPA |
||||||
| Formulation Capacity (Liquid) KLPA |
||||||
| Number of B2C Distributors Number |
||||||
| Overall Capacity Utilization % |
||||||
| Product Registrations (CIB/Export) Number |
||||||
| Revenue contribution from New Product Launches (past 3 years) % |
||||||
| Working Capital Cycle Days |
||||||
| Number of Products/SKUs Number |
||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
2 Jun - Submission of the Transcript of Q4 FY 2025-26 Earning Conference Call held on May 29, 2026
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
29 May - Audio recording of analyst/investor call held May 29, 2026 for Q4 FY25-26 audited results.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
29 May - The newspaper advertisement for the financial results for the quarter and year ended 31 March, 2026
-
Announcement under Regulation 30 (LODR)-Change in Management
28 May - Board approved FY26 audited standalone and consolidated results; auditors issued unmodified opinion; secretarial, cost and internal auditors appointed.
-
Result- Financial Results For March 31 2026
28 May - Board approved FY26 audited standalone and consolidated results, unmodified audit reports, and appointed auditors.
Annual reports
Concalls
-
Jun 2026Transcript PPT
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT
-
Aug 2025Transcript PPT
Business Profile[1]
Indogulf Cropsciences Limited is an agrochemical company engaged in the manufacturing and marketing of crop protection products, plant nutrients, and biologicals. It operates across India and exports to over 34 countries. It serves both retail (B2C) and institutional (B2B) customers and also offers contract manufacturing services.